Guidance document - Nonprescription topical nasal decongestants labelling standard (English, HTML)

View metadata and access the original English HTML file: Guidance document - Nonprescription topical nasal decongestants labelling standard.

Format

HTML

Access

file-only

Publisher-reported update

2021-09-09

This labelling standard describes the requirements necessary to receive market authorisation ( Drug identification number (DIN)) for nonprescription topical nasal decongestant products containing oxymetazoline hydrochloride or xylometazoline hydrochloride as a single ingredient for use in adults and children 12 years of age and older to relieve nasal congestion.

Access original file